Randomized Controlled Trial on Effect of Endosonography-guided Celiac Plexus Neurolysis in Patients with Unresectable Pancreatic Cancer Pain

Randomized Controlled Trial on Effect of Endosonography-guided Celiac Plexus Neurolysis in Patients with Unresectable Pancreatic Cancer Pain - RCT evaluating efficacy of EUS-CPN

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000037172

Enrollment

Registered

2019-06-27

Start date

2019-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic cancer with pain

Interventions

EUS-guided celiac plexus neurolysis (EUS-CPN) Medication alone

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: patients suffering from pain due to unresectable pancreatic cancer

Exclusion criteria

Exclusion criteria: 1. age < 18 years 2. Ht < 30% 3. Hb < 10g/dL 4. Plt < 60,000/mm^3 5. PT-INR > 1.4 6. active infection 7. pregnancy 8. massive ascites 9. allergy for applied drugs

Design outcomes

Primary

Measure	Time frame
Pain level 4 weeks after starting treatment	—

Countries

Japan

Contacts

Public ContactYoshihide Kanno

Sendai City Medical Center Department of Gastroenterology

yoshi-hk@openhp.or.jp022-252-1111

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026